Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
BMS-777607: From MET Biology to Translational Assays
2026-09-25
BMS-777607 offers a useful way to perturb signaling across the MET receptor family. Here, we examine its cancer metastasis research evidence, explain how to design interpretable assays, and assess a carefully bounded connection to emerging hiPSC-derived platelet workflows.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-25
This study develops patient-derived gastric cancer assembloids by combining tumor organoids with stromal cell populations obtained from the same tumor. The model captures tumor–stroma effects on gene expression and drug sensitivity, offering a more context-rich platform for studying gastric cancer biology and evaluating therapeutic hypotheses.
-
SP2509 Workflows for AML Epigenetics Research
2026-09-24
SP2509 offers a potent way to interrogate LSD1-dependent chromatin regulation in acute myeloid leukemia research, with workflows that connect target engagement to differentiation, apoptosis, and colony growth. This guide pairs practical dosing and troubleshooting with a careful comparison to breast-cancer co-targeting research—without implying the studies share a mechanism.
-
Afatinib in Cell Assays: Practical Design and Interpretation
2026-09-24
Learn how to use Afatinib (SKU A4746) to investigate ErbB signaling in viability and cytotoxicity assays, from solvent preparation to interpretation in tumor–stroma models. Practical guidance is grounded in product specifications and recent patient-derived gastric cancer assembloid research.
-
Dacomitinib and the Translational Logic of Cell Death
2026-09-23
Dacomitinib (PF-00299804) offers a way to probe ErbB-driven signaling, while emerging METTL17 findings raise distinct questions about mitochondrial ferroptosis resistance. This article separates established evidence from testable cross-domain hypotheses and outlines a translational research strategy.
-
FKBP9, Glioblastoma Malignancy, and ER Stress Resistance
2026-09-23
Xu et al. identify FKBP9 as a clinically unfavorable and mechanistically active determinant of glioblastoma behavior. Their experiments connect FKBP9 to ASK1–p38MAPK signaling, IRE1α–XBP1 regulation, tumor growth, and resistance to pharmacologically induced endoplasmic reticulum stress.
-
Dye Models for Small Biopsy Visibility in Histology
2026-09-22
The reference study evaluates whether colored dye markers can improve recognition and retention of very small biopsy specimens during routine tissue processing. Its central practical finding is that hematoxylin, merbromin, and Alcian Blue improved visibility, while hematoxylin offered the most favorable balance of observability, safety, and compatibility with diagnostic microscopy.
-
Cell Death in Liver Disease: Mechanisms and Clinical Relevan
2026-09-22
This review reframes hepatocellular death as an active driver of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma rather than merely a marker of liver injury. Its central contribution is a context-dependent framework distinguishing apoptosis, necrosis, and necroptosis while connecting cell-death responses with biomarkers, disease models, and therapeutic opportunities.
-
Afatinib in Gastric Cancer Assembloid Research
2026-09-21
Afatinib, also known as BIBW 2992, gives researchers an irreversible ErbB-family perturbation tool for comparing tumor organoids with patient-matched stromal assembloids. This workflow shows how to connect EGFR, HER2, and HER4 pathway biology with practical drug-response, resistance, and tumor–stroma assays.
-
Mucocutaneous Candidiasis: Diagnosis and Treatment
2026-09-21
This 2009 guideline review organizes mucocutaneous candidiasis by clinical presentation and establishes direct microscopy as the decisive diagnostic test when Candida is suspected. Its practical contribution is a risk-based treatment framework that prioritizes topical imidazoles for cutaneous disease while reserving systemic therapy for nail, oral, extensive, recurrent, or deep infection.
-
Estradiol Workflows for ER–Autophagy Studies
2026-09-20
Build reproducible 17 beta-estradiol assays that connect estrogen receptor signaling with autophagy, fibrosis, and tissue-protection readouts. This practical guide distinguishes receptor-specific effects from vehicle, timing, and flux artifacts across cardiovascular and renal research models.
-
Praeruptorin A: From Mechanism to Translation
2026-09-19
Praeruptorin A is an angular pyranocoumarin compound with a distinctive translational profile spanning iron-dependent cell death, inflammation, tissue barrier protection, cardiomyopathy research, and tumor invasion. This article frames how researchers can convert its multi-pathway biology into better-controlled preclinical decisions.
-
Coumestrol Drives Ferroptosis in RA Fibroblasts
2026-09-18
A 2026 study identifies a TRIM3–PMAIP1 regulatory axis through which Coumestrol promotes ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. The findings connect mitochondrial protein stabilization with reduced synoviocyte proliferation and inflammatory cytokine production, while highlighting the need for validation in primary cells and in vivo models.
-
Neuritin, ER Stress, and NF-κB After SAH
2026-09-18
A 2024 Brain Research study examines how neuritin limits early brain injury after subarachnoid hemorrhage by suppressing three endoplasmic-reticulum-stress-related inflammatory routes that converge on NF-κB. Its integrated model connects ER stress, neuroinflammation, and neuronal apoptosis, while suggesting experimental strategies for testing pathway convergence rather than treating NF-κB as an isolated endpoint.
-
Tunicamycin for ER Stress Research
2026-09-17
Tunicamycin is a mechanistically direct N-glycosylation inhibitor for connecting glycoprotein processing defects with unfolded protein response signaling. This guide translates the compound into practical workflows for RAW264.7 macrophages, glioblastoma stress-resistance studies, and reproducible assay troubleshooting.